Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs
Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …
addressing drug allergy and hypersensitivity due to the increase in drug reactions …
HIV-1 integrase inhibitors: a comparative review of efficacy and safety
KK Scarsi, JP Havens, AT Podany, SN Avedissian… - Drugs, 2020 - Springer
The newest class of antiretrovirals for all persons living with HIV are the integrase strand
transfer inhibitors (INSTIs). Since 2007, five INSTIs have been introduced: raltegravir …
transfer inhibitors (INSTIs). Since 2007, five INSTIs have been introduced: raltegravir …
Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016
JL Marcus, WA Leyden, SE Alexeeff… - JAMA network …, 2020 - jamanetwork.com
Importance Antiretroviral therapy (ART) has improved life expectancy for individuals with HIV
infection, but recent data comparing life span and comorbidity-free years by HIV status are …
infection, but recent data comparing life span and comorbidity-free years by HIV status are …
Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis
Objective To characterize the prevalence and burden of HIV-associated neurocognitive
disorder (HAND) and assess associated factors in the global population with HIV. Methods …
disorder (HAND) and assess associated factors in the global population with HIV. Methods …
Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational …
Background. There is conflicting evidence about how HIV infection influences COVID-19.
We compared the presentation characteristics and outcomes of people with and without HIV …
We compared the presentation characteristics and outcomes of people with and without HIV …
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response
To affect the COVID-19 pandemic, lifesaving antiviral therapies must be identified. The
number of clinical trials that can be performed is limited. We developed mathematical …
number of clinical trials that can be performed is limited. We developed mathematical …
Cognitive disorders in people living with HIV
High rates of cognitive disorders in antiretroviral-treated people living with HIV have been
described worldwide. The exact prevalence of such cognitive disorders is determined by the …
described worldwide. The exact prevalence of such cognitive disorders is determined by the …
[HTML][HTML] Highly active antiretroviral therapy (HAART)
JS Eggleton, S Nagalli - 2020 - europepmc.org
Objectives: Describe the treatment considerations for patients with HIV. Identify the most
common adverse events associated with highly active antiretroviral therapy (HAART) …
common adverse events associated with highly active antiretroviral therapy (HAART) …
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
D Havlir, S Lockman, H Ayles… - Journal of the …, 2020 - Wiley Online Library
Introduction Achieving HIV epidemic control globally will require new strategies to
accelerate reductions in HIV incidence and mortality. Universal test and treat (UTT) was …
accelerate reductions in HIV incidence and mortality. Universal test and treat (UTT) was …
[HTML][HTML] Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining challenges
W Cao, E Hsieh, T Li - Current HIV/AIDS Reports, 2020 - Springer
Abstract Purpose of Review The introduction of the National Free Antiretroviral Therapy
Program (NFATP) in 2003 by the China National Center for AIDS/STD Control and …
Program (NFATP) in 2003 by the China National Center for AIDS/STD Control and …